用阿纳金拉治疗的COVID-19患者中的生物标志物的动态
Ralitsa Yordanova1, Dimitar Strashimirov1, Rusina Grozdeva1
1Department of Infectious Diseases, Parasitology and Tropical Medicine, Medical University Sofia, 1431 Sofia, Bulgaria.
Biomedicines
|January 8, 2025
概括
阿纳金拉降低了炎症生物标志物,并在严重的COVID-19患者中改善了氧化,但没有影响生存率. 需要进一步的研究来证实这些发现.
科学领域:
- 免疫学和传染病的研究
- 关键护理医学 关键护理医学
- 药理学 药理学是指药理学的学科.
背景情况:
- 严重的COVID-19的特征是高炎症,导致肺炎,ARDS和器官衰竭.
- 关键生物标志物 (白细胞,CRP,NLR,AST,LDH,D-二次体,费里丁,IL-6) 表明疾病的严重程度.
- 作为IL-1受体对抗剂的阿纳金拉是COVID-19高炎症的潜在治疗方法,但它的有效性需要验证.
研究的目的:
- 评估阿纳金拉对住院患者中度至重度COVID-19炎症生物标志物的影响.
- 与标准治疗相比,评估阿纳金拉对氧化状态和生存结果的影响.
主要方法:
- 对65名中度至重度COVID-19住院患者的回顾性分析.
- 两组:标准治疗 (对照组,n=24) 和阿纳金拉治疗 (目标组,n=41).
- 评估生物标志物 (白细胞,NLR,CRP,AST,LDH,D-二次体,费里丁,IL-6) 和在第0,3和第7天的氧化.
主要成果:
- 在第3天和第7天,阿纳金拉显著降低了白细胞,NLR,D-二次体,费里丁,IL-6和CRP.
- 在Anakinra组中观察到改善的氧化状态.
- 没有发现显著的生存益处;对照组显示生物标志物的变化很小.
结论:
- 阿纳金拉在缓解高炎症和改善中度至重度COVID-19中的氧化方面表现有前途.
- 这项研究没有发现Anakinra治疗改善了生存的证据.
- 需要进一步的临床试验来证实这些初步发现,并评估阿纳金拉在COVID-19管理中的作用.
相关概念视频
01:20The JAK-STAT Signaling Pathway
8.7K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
8.7K
01:20Blood Studies for Cardiovascular System I: Cardiac Biomarkers
96
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
96
01:24Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
114
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
114
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
56
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
56